Ijzer (Iii)carboxymaltose Sandoz

Ferric carboxymaltose, the active ingredient in Ijzer (Iii)carboxymaltose Sandoz, is a Iron(III) carbohydrate complex presented as a solution for injection for intravenous use. It treats iron deficiency anemia in patients who require parenteral iron therapy.

GNH USA supplies Ijzer (Iii)carboxymaltose Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ferric carboxymaltose is used to treat iron deficiency anemia, a condition characterized by insufficient iron for normal red blood cell production.

- Iron deficiency anemia in chronic kidney disease: restores hemoglobin levels and reduces the need for blood transfusion. - Iron deficiency anemia in inflammatory bowel disease: provides rapid iron repletion when oral iron is poorly absorbed. - Iron deficiency anemia in pregnancy or postpartum (when oral iron is ineffective): corrects iron stores and improves maternal health.

Adverse reactions may occur with intravenous iron administration.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: transient cranial discomfort. - Dizziness: temporary light‑headedness. - Injection site reactions: pain, erythema, or swelling. - Flushing: brief warmth or redness. - Mild hypotension: transient drop in blood pressure.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe hypotension: marked blood pressure decrease during infusion. - Acute hypersensitivity: rash, bronchospasm, or angioedema. - Iron overload: excessive iron accumulation with long‑term use. - Cardiac arrest: rare but life‑threatening event. - Severe injection site necrosis: tissue death at the infusion site.

Ferric carboxymaltose should be administered with careful clinical assessment.

- Assess iron status: confirm iron deficiency before initiating therapy. - Monitor hemoglobin: check levels during and after treatment. - Avoid in known hypersensitivity: do not use if the patient has reacted to ferric carboxymaltose or its excipients. - Use cautiously with active infection: iron may promote bacterial growth. - Observe for hypotension: monitor blood pressure during infusion. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ferric carboxymaltose may interact with other medicines.

Major Interactions (Avoid): - Other intravenous iron preparations: risk of iron overload. - Known hypersensitivity to ferric carboxymaltose or excipients: may trigger severe allergic reaction. - High‑dose vitamin C: can increase free iron and oxidative stress.

Moderate Interactions (Monitor Closely): - Oral iron supplements: may reduce absorption if given concurrently; separate administration times. - Erythropoiesis‑stimulating agents: monitor hemoglobin rise to avoid excessive levels. - Antihypertensive drugs: watch for additive hypotensive effects during infusion.